Lower Risk of One-Year Non-Relapse Mortality, Rapid Engraftment and Better NK Cell Recovery With GvHD Prophylaxis Based in Post-Transplant Cyclophosphamide/Bendamustine in Pediatric Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2018.12.248
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2019
Authors
Publisher
Elsevier BV